11.52USD-0.13%Mkt Cap: 679.53M USDP/E: 5.72Last update: 2026-06-01
Zevra Therapeutics, Inc., a commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States. The company develops its products through Ligand Activated Technology platf…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap679.53M USD
Enterprise Value486.27M USD
Revenue (TTM)122.29M USD
Gross Profit89.99M USD
Net Income (TTM)83.23M USD
Revenue/Share2.169 USD
Last Price11.52 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees61
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)5.72
P/E (Forward)6.05
PEG10.67
EV/EBITDA38.19
EV/Revenue3.98
P/S5.60
P/B4.26
EPS (TTM)2.01
EPS (Forward)1.92
52W Range
7.16073% of range13.16
52W High13.16 USD
52W Low7.160 USD
Profitability
Gross Margin84.52%
Oper. Margin24.38%
EBITDA Margin10.41%
Profit Margin78.17%
ROE53.82%
ROA29.23%
Growth
Revenue Growth77.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.60M USD
CapEx (TTM)835.00K USD
FCF Margin21.14%
FCF Yield3.80%
Net Debt-199.47M USD
Net Debt/EBITDA-15.66
Balance Sheet
Debt/Equity0.41
Current Ratio4.89
Quick Ratio4.74
Book Value/Sh2.720 USD
Cash/Share3.394 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateDec 28, 2020
Splits
Last Split1:16
Split DateDec 28, 2020
Analyst Consensus
Rating—
Target (Mean)23.00 USD
Target Range18.00 USD – 26.00 USD
# Analysts9
Ownership
Shares Out.59.12M
Float54.96M
Insiders1.40%
Institutions70.73%
Short Interest
Short Ratio3.5d
Short % Float7.60%
Short % Out.7.52%
Shares Short4.44M
Short (prev mo.)4.78M
Technical
SMA 5010.15 (+13.5%)
SMA 2009.387 (+22.7%)
Beta0.88
S&P 52W Chg27.70%
Avg Vol (30d)1.51M
Avg Vol (10d)2.15M
Technical Indicators
RSI (14)61.6
MACD0.2128
MACD Signal0.1797
MACD Hist.+0.0331
BB Upper11.79 USD
BB Middle10.76 USD
BB Lower9.729 USD
BB Width19.16%
ATR (14)0.5945 USD
Vol Ratio (20d)0.80x